Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial

Clinical trial NCT03301779 · COMPLETED

Trial details

NCT number: NCT03301779
Sponsor: Hemanext
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Whole Blood Donation and Leukoreduction

Start date: 2017-11-27
Primary completion: 2019-03-06
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.